NCT02226536

Brief Summary

Introduction: the global sugar consumption has increased in the past 50 years and their abusive intake is responsible for the insulin resistance and causes the metabolic syndrome - obesity, diabetes mellitus, hypertension and coronary heart disease. Objective: To evaluate the effect of scheduled diet without glucose as treatment of labyrinthine disorders associated with glucose-insulin index. Study Design: A prospective randomized controlled trial. Patients and Methods: A study conducted at the University of São Paulo with 51 patients divided into two groups: Diet Group (DG) that comprises subjects treated with fractionated diet with glucose restriction and control group (CG) where individuals were not counseled regarding diet. Patients underwent computerized dynamic posturography - sensory organization test (CDP - SOT) and Visual Analog Scale (VAS) in the first and thirtieth days of the study.

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
51

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Dec 2005

Longer than P75 for not_applicable

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

December 1, 2005

Completed
5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2010

Completed
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2011

Completed
2.7 years until next milestone

First Submitted

Initial submission to the registry

August 6, 2014

Completed
21 days until next milestone

First Posted

Study publicly available on registry

August 27, 2014

Completed
Last Updated

June 14, 2022

Status Verified

June 1, 2022

Enrollment Period

5 years

First QC Date

August 6, 2014

Last Update Submit

June 9, 2022

Conditions

Keywords

PostureVertigoglucose metabolismdietscalesdinamic posturography

Outcome Measures

Primary Outcomes (1)

  • Assessment of equilibrium score through the computerized dynamic posturography (CDP) in 51 patients

    30 days

Secondary Outcomes (1)

  • Self perception of dizziness mesured by the visual analogue scale

    30 days

Study Arms (2)

control

PLACEBO COMPARATOR

Usual diet without any orientation

Behavioral: fractioned diet without glucose

fractioned diet without glucose

ACTIVE COMPARATOR

Fractioned diet without glucose

Behavioral: fractioned diet without glucose

Interventions

Patients were divided into two groups: Diet Group was treated with placebo pills and glucose restrictive and fractionated diet. Control Group received only placebo pills. All individuals had their vestibular function evaluated by Computerized Dynamic Posturography and done visual analogue scale (VAS) in the first day and 30 days after diet intervention

controlfractioned diet without glucose

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • dizziness related to fasting or glucose intake
  • alterations of glucose tolerance test

You may not qualify if:

  • dizziness not related to vestibular problems
  • ortopedical or neurological diseases
  • diabetes mellitus

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Glucose IntoleranceVertigo

Interventions

Glucose

Condition Hierarchy (Ancestors)

HyperglycemiaGlucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesVestibular DiseasesLabyrinth DiseasesEar DiseasesOtorhinolaryngologic DiseasesNeurologic ManifestationsNervous System DiseasesSigns and SymptomsPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

HexosesMonosaccharidesSugarsCarbohydrates

Study Officials

  • Roseli SM Bittar, MD, PhD

    University of Sao Paulo

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistente Doutor da Faculdade de Medicina da Universidade de São Paulo

Study Record Dates

First Submitted

August 6, 2014

First Posted

August 27, 2014

Study Start

December 1, 2005

Primary Completion

December 1, 2010

Study Completion

December 1, 2011

Last Updated

June 14, 2022

Record last verified: 2022-06